Organ-specific autoantibodies with muscle weakness.

The motor unit includes the anterior horn cell, the motor axon and the muscle fibers it innervates, and the neuromuscular junction. Diseases of the motor unit usually present with weakness. Diagnosis of motor unit disorders involves the history, physical examination, electrophysiologic studies of nerve and muscle, and blood testing for creatine kinase, genetic disorders, and autoantibodies. Antibody testing is often useful for the identification of specific immune-mediated motor unit disorders. Identification of these disorders is important because they are often treatable. Antibodies with disease specificity include those directed against autoantigens with and without organ specificity. Several autoantibodies to non-organ-specific antigens are associated with subgroups of immune myopathies. Organ-specific autoantibodies in motor unit disorders with weakness occur in myasthenia gravis, especially with thymoma, a myopathy associated with Waldenstrom's macroglobulinemia, Lambert-Eaton myasthenic syndrome, and multifocal motor neuropathy.

[1]  M. Hook,et al.  Dermatomyositis associated with bronchiolitis obliterans organizing pneumonia (BOOP). , 1999, Journal of the American Academy of Dermatology.

[2]  A. Nagai,et al.  Fas and Fas ligand interaction induces apoptosis in inflammatory myopathies: CD4+ T cells cause muscle cell injury directly in polymyositis. , 1999, Arthritis and rheumatism.

[3]  R. Griggs,et al.  Spontaneous abdominal hematoma in dermatomyositis , 1998, Muscle & nerve.

[4]  Salvatore,et al.  Amyopathic dermatomyositis: report of three cases , 1998, The British journal of dermatology.

[5]  T. Slongo,et al.  Tumoral Calcinosis and Atypical Juvenile Dermatomyositis: Case Report , 1998, European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie.

[6]  K. Flanigan,et al.  Calciphylaxis mimicking dermatomyositis , 1998, Neurology.

[7]  M. Dalakas,et al.  Molecular immunology and genetics of inflammatory muscle diseases. , 1998, Archives of neurology.

[8]  Yazawa,et al.  Serum concentrations of vascular endothelial growth factor in collagen diseases , 1998, The British journal of dermatology.

[9]  N. Okada,et al.  A Case of Calcinosis Universalis Successfully Treated with Low‐Dose Warfarin , 1998, The Journal of dermatology.

[10]  M. Dimachkie,et al.  Phenytoin-Induced Dermatomyositis: Case Report and Literature Review , 1998, Journal of child neurology.

[11]  I. Lundberg,et al.  New developments in the role of cytokines and chemokines in inflammatory myopathies. , 1998, Current opinion in rheumatology.

[12]  J. Borrás-Blasco,et al.  Alfuzosin-associated dermatomyositis. , 1998, British journal of rheumatology.

[13]  Kishimoto,et al.  Hydroxyurea dermopathy with a dermatomyositis‐like eruption and a large leg ulcer , 1998, The British journal of dermatology.

[14]  H. Chan,et al.  Amyopathic dermatomyositis in Hong Kong – association with nasopharyngeal carcinoma , 1998, International journal of dermatology.

[15]  P. Merry,et al.  Tumour markers in dermatomyositis: useful or useless? , 1998, British journal of rheumatology.

[16]  I. Rosner,et al.  Dermatomyositis and Nasopharyngeal Carcinoma , 1998, The Journal of dermatology.

[17]  Kemény,et al.  Correspondence. Panniculitis in dermatomyositis: report of two cases , 1998, The British journal of dermatology.

[18]  M. Feinmesser,et al.  Adult dermatomyositis with livedo reticularis and multiple skin ulcers , 1998, Journal of the European Academy of Dermatology and Venereology : JEADV.

[19]  X. Bosch Leishmaniasis mimicking new-onset juvenile dermatomyositis: comment on the article by Pachman et al. , 1998, Arthritis and rheumatism.

[20]  N. Olsen,et al.  Analysis of 31P MR spectroscopy data using artificial neural networks for longitudinal evaluation of musclediseases: dermatomyositis , 1998, NMR in biomedicine.

[21]  H. Goebel,et al.  Cell death and oxidative damage in inflammatory myopathies. , 1998, Clinical immunology and immunopathology.

[22]  O. S. Kwon,et al.  Apoptosis in the pathogenesis of cutaneous lupus erythematosus. , 1998, The American Journal of dermatopathology.

[23]  B. Kirby,et al.  Hydroxyurea-induced dermopathy: a unique lichenoid eruption complicating long-term therapy with hydroxyurea. , 1998, Journal of the American Academy of Dermatology.

[24]  Greiner,et al.  Dermatomyositis presenting as plaque‐like mucinosis , 1998, The British journal of dermatology.

[25]  C. Cockerell,et al.  Vesiculo-bullous dermatomyositis. , 1998, The American Journal of dermatopathology.

[26]  A. Jones,et al.  Dermatomyositis—how far to go! , 1998, Annals of the rheumatic diseases.

[27]  F. Walker,et al.  Dermatomyositis: a dermatology-based case series. , 1998, Journal of the American Academy of Dermatology.

[28]  C. Paschalis,et al.  Polymyositis and pregnancy: report of a case with three pregnancies , 1998, Journal of neurology, neurosurgery, and psychiatry.

[29]  Gherardi,et al.  Dermatomyositis‐like graft‐versus‐host disease , 1998, The British journal of dermatology.

[30]  Pellissier,et al.  Local expression of cytokines in idiopathic inflammatory myopathies , 1998, Neuropathology and applied neurobiology.

[31]  T. Ohtsuka The relation between nailfold bleeding and capillary microscopic abnormality in pateints with connective tissue diseases , 1998, International journal of dermatology.

[32]  R. Sontheimer,et al.  Amyopathic dermatomyositis (dermatomyositis siné myositis). Presentation of six new cases and review of the literature. , 1991, Journal of the American Academy of Dermatology.

[33]  B. Mathes,et al.  Periorbital Edema as the Presenting Sign of Juvenile Dermatomyositis , 1999, Pediatric dermatology.

[34]  R. Sontheimer,et al.  Amyopathic dermatomyositis: a review. , 1993, The Journal of investigative dermatology.